Utah Mom With Stage 4 Cancer Undergoes Rare Double-Lung Transplant

Kelsey Flake, a 39-year-old Utah mother of five, has traveled to Northwestern Medicine to begin a rare double-lung transplant process after battling Stage 4 lung cancer.

Flake’s medical journey took a severe turn in January when her cancer returned in both lungs following an intensive regimen of chemotherapy, surgery, and immunotherapy. Despite pursuing subsequent aggressive treatments, the disease continued to advance. According to KUTV reporting, Flake arrived in Chicago with her lung capacity reduced to 41%, requiring continuous supplemental oxygen.

Inside Northwestern Medicine’s Specialized DREAM Program

The evaluation process centers on Northwestern Medicine’s DREAM program. This specialized clinical protocol offers double-lung transplants to highly selected patients whose advanced cancer is confined to the lungs and no longer responds to standard care. Surgeons are expected to remove at least one lung first before listing the patient for donor lungs.

Evaluating the Clinical Data: Survival Curves and Risk

Data published in a July study in JAMA analyzing 98 such patients provided a detailed look at comparative outcomes. Among 17 transplant recipients identified in the cohort, the estimated one-year survival rate reached 100%. By comparison, medically managed patients in the matched group experienced an estimated one-year survival rate of 40.8%. Researchers emphasized, however, that longer-term outcomes still need study to fully characterize recurrence risks.

Logistical Realities and Family Impact

The specialized nature of the evaluation and potential surgical intervention requires Flake and her husband to relocate to Chicago for several months. Meanwhile, their five children remain initially in Utah, supported by community fundraising efforts. These auxiliary campaigns are vital for managing the substantial financial hurdles associated with housing, travel, childcare, and transplant-related costs.

In Plain English: The Clinical Takeaway

Contraindications & When to Consult a Doctor

As Flake undergoes her initial evaluations in Chicago, her case underscores the evolving boundaries of thoracic oncology. While programs like Northwestern’s DREAM initiative offer a path forward for patients with limited options, the medical community continues to monitor long-term survival data and recurrence patterns closely.

Photo: zetik.com

References

• Journal of the American Medical Association (JAMA): Studies on pulmonary transplantation outcomes in advanced malignancy cohorts.
• Northwestern Medicine: Clinical trial designs and patient selection criteria for the DREAM program.